Literature DB >> 27003739

A Review of Monocytes and Monocyte-Derived Cells in Hypertrophic Scarring Post Burn.

Sasithorn Suda1, Helen Williams, Heather J Medbury, Andrew J A Holland.   

Abstract

Pediatric burns remain a common injury after which many patients develop a severe form of scarring known as hypertrophic scarring. The formation of the hypertrophic scar arises from excessive production of collagen during wound healing. Wound repair and regeneration represents a complex process that is accomplished through many biological processes involving various cell types, extracellular matrix proteins, cytokines, and other mediators. One important cell type is the monocyte, which displays an altered profile in many wound models. These profile changes may function as biomarkers, reflecting and/or influencing the clinical outcome of the healing response seen after burn injury. Monocytes circulate in the blood and then enter into the tissue, where they further differentiate into macrophages, which serve various functions, including immune defense and tissue remodeling. More recently, these cells have been characterized in detail based on cell surface markers expressed and genes up-regulated, enabling subpopulations to be identified. Fibrocytes, which are also monocyte-derived cells, have been shown to contribute to collagen production in the burn wound and are associated with hypertrophic scarring. They may represent a unique subpopulation of macrophages that, due to their production of collagen, promote tissue fibrosis rather than wound repair. A better understanding of the relationship among monocytes, fibrocytes, and macrophages may improve our appreciation of the factors influencing scar formation and tissue remodeling.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27003739     DOI: 10.1097/BCR.0000000000000312

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  7 in total

1.  The clinical dynamic changes of macrophage phenotype and function in different stages of human wound healing and hypertrophic scar formation.

Authors:  Lin Chen; Jianzhang Wang; Shengxu Li; Zhou Yu; Bei Liu; Baoqiang Song; Yingjun Su
Journal:  Int Wound J       Date:  2018-11-15       Impact factor: 3.315

2.  Temporal shifts in the mycobiome structure and network architecture associated with a rat (Rattus norvegicus) deep partial-thickness cutaneous burn.

Authors:  Fatemeh Sanjar; Alan J Weaver; Trent J Peacock; Jesse Q Nguyen; Kenneth S Brandenburg; Kai P Leung
Journal:  Med Mycol       Date:  2020-01-01       Impact factor: 4.076

3.  Fibrocyte migration, differentiation and apoptosis during the corneal wound healing response to injury.

Authors:  Luciana Lassance; Gustavo K Marino; Carla S Medeiros; Shanmugapriya Thangavadivel; Steven E Wilson
Journal:  Exp Eye Res       Date:  2018-02-24       Impact factor: 3.467

4.  Prognostic tools for hypertrophic scar formation based on fundamental differences in systemic immunity.

Authors:  Erik de Bakker; Mirthe A M van der Putten; Martijn W Heymans; Sander W Spiekstra; Taco Waaijman; Liselotte Butzelaar; Vera L Negenborn; Vivian K Beekman; Erman O Akpinar; Thomas Rustemeyer; Frank B Niessen; Susan Gibbs
Journal:  Exp Dermatol       Date:  2020-08-17       Impact factor: 3.960

5.  CCN2/CTGF-A Modulator of the Optic Nerve Head Astrocyte.

Authors:  Andrea E Dillinger; Gregor R Weber; Matthias Mayer; Magdalena Schneider; Corinna Göppner; Andreas Ohlmann; Mikhail Shamonin; Gareth J Monkman; Rudolf Fuchshofer
Journal:  Front Cell Dev Biol       Date:  2022-04-14

Review 6.  The Role of the Immune System in Pediatric Burns: A Systematic Review.

Authors:  Tomasz Korzeniowski; Paulina Mertowska; Sebastian Mertowski; Martyna Podgajna; Ewelina Grywalska; Jerzy Strużyna; Kamil Torres
Journal:  J Clin Med       Date:  2022-04-18       Impact factor: 4.964

7.  Investigation of the long-term healing response of the liver to boiling histotripsy treatment in vivo.

Authors:  Jeongmin Heo; Chanmin Joung; Kisoo Pahk; Ki Joo Pahk
Journal:  Sci Rep       Date:  2022-08-24       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.